The Top 7 Monoclonal Antibody Drugs in 2024 will Target Inflammation and Cancer

Recent Advances in Treatment of Stage IV Metastatic Breast Cancer: Anti-HER2 mAbs, TKIs, and ADCs

Advances in Treatment of Stage IV Metastatic Non-Small Cell Lung Cancer: The Role of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and Tyrosine Kinase Inhibitors

Antibody-based Therapies for Alzheimer’s Disease: Failures and Future Outlook

Antibody Drug Conjugates (ADCs): Next in Line for Cancer Therapeutics